Lol! It's not a new desease, rather the surgical procedure i underwent. There just so much information on the net, i'm finding out new stuff all the time.
The Whipple Procedure
Also called a pancreaticoduodenectomy, which is generally the removal of the gallbladder, common bile duct, part of the duodenum, and the head of the pancreas.
This operation was first described by .Dr. Alan O. Whipple of New York Memorial Hospital (now called Memorial Sloan-Kettering). Since that time, there have been many modifications and improvements of the procedure. There is a detailed account of the operative mortality rates and long-term survival rates in the Surgical Treatment and Research section of this site.
There are several variations of "the Whipple" currently practiced:
Standard Whipple with lymph node dissection
Read more and see pictures here
And some good news about survival rates post-Whipple:
Summary
In recent years the surgical treatment of adenocarcinoma of the head, neck or uncinate process of the pancreas via pancreaticoduodenectomy has been associated with falling postoperative morbidity and mortality rates and improving long-term survival. The results from our recent single institution experience demonstrate an actuarial five-year survival of 21% for all patients undergoing pancreaticoduodenal resection for adenocarcinoma of the pancreas. Importantly, the actuarial five-year survival is improved for patients resected with tumors less than 3 cm in diameter (28%), negative margins (26%), negative nodal involvement (36%), or diploid tumor DNA content (39%). Multivariate analysis indicated that the parameters that serve as the strongest independent predictors of favorable outcome are tumor DNA content, tumor diameter, status of resected lymph nodes, margin status, and decade of resection (resection in the 1990s being most favorable). The increasing use of postoperative combined modality chemoradiation therapy appears to be another factor favoring long-term survival.
This large series from The Johns Hopkins Hospital provides room for cautious optimism in the treatment of pancreatic adenocarcinoma. The development of more promising adjuvant therapies, such as strategies combining chemoradiation with immunotherapy, may further enhance survival. Additionally, developments in the field of molecular genetics hold promise for the earlier detection of pancreatic cancer, possibly using gene-based diagnostic modalities.
From the Johns Hopkins website, read more here
More about Pancreatic cancer
What is it?
Is it hereditary?
Different types mine was endocrine (at bottom of page)
The Whipple Procedure
Also called a pancreaticoduodenectomy, which is generally the removal of the gallbladder, common bile duct, part of the duodenum, and the head of the pancreas.
This operation was first described by .Dr. Alan O. Whipple of New York Memorial Hospital (now called Memorial Sloan-Kettering). Since that time, there have been many modifications and improvements of the procedure. There is a detailed account of the operative mortality rates and long-term survival rates in the Surgical Treatment and Research section of this site.
There are several variations of "the Whipple" currently practiced:
Standard Whipple with lymph node dissection
Read more and see pictures here
And some good news about survival rates post-Whipple:
Summary
In recent years the surgical treatment of adenocarcinoma of the head, neck or uncinate process of the pancreas via pancreaticoduodenectomy has been associated with falling postoperative morbidity and mortality rates and improving long-term survival. The results from our recent single institution experience demonstrate an actuarial five-year survival of 21% for all patients undergoing pancreaticoduodenal resection for adenocarcinoma of the pancreas. Importantly, the actuarial five-year survival is improved for patients resected with tumors less than 3 cm in diameter (28%), negative margins (26%), negative nodal involvement (36%), or diploid tumor DNA content (39%). Multivariate analysis indicated that the parameters that serve as the strongest independent predictors of favorable outcome are tumor DNA content, tumor diameter, status of resected lymph nodes, margin status, and decade of resection (resection in the 1990s being most favorable). The increasing use of postoperative combined modality chemoradiation therapy appears to be another factor favoring long-term survival.
This large series from The Johns Hopkins Hospital provides room for cautious optimism in the treatment of pancreatic adenocarcinoma. The development of more promising adjuvant therapies, such as strategies combining chemoradiation with immunotherapy, may further enhance survival. Additionally, developments in the field of molecular genetics hold promise for the earlier detection of pancreatic cancer, possibly using gene-based diagnostic modalities.
From the Johns Hopkins website, read more here
More about Pancreatic cancer
What is it?
Is it hereditary?
Different types mine was endocrine (at bottom of page)
Comments